How does blood pressure variability lead to poor outcomes in acute neurological injury such as traumatic brain injury, intracerebral hemorrhage, or ischemic stroke?

Blood Pressure Variability Leads to Poor Outcomes in Acute Neurological Injury Through Multiple Mechanisms of Secondary Brain Injury

Blood pressure variability (BPV) independently predicts worse neurological outcomes, increased mortality, and greater disability across traumatic brain injury, intracerebral hemorrhage, and ischemic stroke by causing fluctuations in cerebral perfusion that exacerbate secondary brain injury, particularly in the setting of impaired cerebral autoregulation.

Core Pathophysiological Mechanisms

Impaired Cerebral Autoregulation as the Central Problem

In acute neurological injury, the brain loses its normal ability to maintain stable cerebral blood flow despite systemic blood pressure changes 1. When autoregulation is impaired—which occurs in 95 patients across ICH studies and 413 patients across SAH studies—cerebral perfusion becomes directly dependent on systemic blood pressure 1. This creates a vulnerable state where:

• Systolic BP peaks cause hyperperfusion → risk of hemorrhagic transformation, hematoma expansion, and increased intracranial pressure
• Systolic BP troughs cause hypoperfusion → ischemic injury to penumbral tissue and worsening of existing injury

The comprehensive review demonstrates that impaired dynamic cerebral autoregulation is directly associated with poor outcomes across both ICH and SAH 1.

Direct Evidence of BPV Impact on Outcomes

In Intracerebral Hemorrhage:

The INTERACT2 post-hoc analysis of 2,645 patients provides the strongest evidence 2. Higher systolic BP variability (measured as standard deviation) showed:

• Hyperacute phase (first 24 hours): Highest quintile had adjusted OR 1.41 (95% CI 1.05-1.90) for death or major disability
• Acute phase (days 2-7): Highest quintile had adjusted OR 1.57 (95% CI 1.14-2.17) for death or major disability
• Maximum systolic BP in hyperacute phase and SD of systolic BP in acute phase were the strongest predictors

A separate study of 138 ICH patients demonstrated dose-response relationships with 3-month poor outcomes 3:

• Highest third of systolic BP SD: adjusted OR 7.95 (95% CI 2.88-21.90)
• Highest third of systolic BP coefficient of variation: adjusted OR 7.74 (95% CI 2.88-20.80)

In Ischemic Stroke:

Analysis of 215 anterior circulation stroke patients showed increased early systolic BPV associated with worse modified Rankin Scale scores at all time intervals (0-24h, 0-72h, 0-120h) 4. This association was strongest in patients with:

• Proximal vessel occlusion
• Lower mean blood pressure
• Despite endovascular or thrombolytic therapy

A 2024 meta-analysis confirmed higher systolic BPV links to increased risk of functional disability, mortality, early neurological deterioration, and stroke recurrence in acute stroke patients without thrombolysis 5.

In Traumatic Brain Injury:

While the TBI guidelines emphasize that episodes of hypotension (SBP <90 mmHg) for even 5 minutes significantly increase morbidity and mortality 6, the principle extends to variability. The Traumatic Coma Data Bank demonstrated that hypotensive episodes are associated with 75% mortality when combined with hypoxemia 6. The guidelines strongly recommend (Grade 1+) investigating and correcting systemic factors of secondary cerebral insults, with French Guidelines recommending maintaining MAP ≥80 mmHg 6.

Why Variability Matters Beyond Mean Blood Pressure

The "Smooth and Sustained Control" Principle

The INTERACT2 analysis revealed that benefits of early intensive BP lowering might be enhanced by smooth and sustained control, particularly by avoiding peaks in systolic BP 2. This suggests that:

1. Fluctuations cause repetitive ischemia-reperfusion injury to vulnerable penumbral tissue
2. BP peaks risk hemorrhagic transformation in ischemic stroke and hematoma expansion in ICH
3. BP troughs compromise perfusion to already-injured brain tissue with impaired autoregulation

Systolic vs. Diastolic Variability

The evidence consistently shows systolic BPV is more predictive than diastolic BPV 2, 4, 3. In the INTERACT2 analysis, associations were significant for systolic but not consistently for diastolic variability 2. One study found diastolic BPV associations were weaker and only significant at higher values 3.

Clinical Implications for BP Management

Avoid Excessive Variability During Treatment

The 2022 Stroke guidelines highlight a critical concern: while intensive BP lowering may be beneficial, the ideal agent should achieve target without excessive BP variability 1. The guidelines note:

• α- and β-adrenoreceptor blockers (labetalol, metoprolol) appeared to have better outcomes compared to other agents
• These may work by blocking the autonomic response that drives hypertensive surges from hematoma presence
• Nicardipine (calcium channel blocker) is favored in North America; urapidil (α-blocker) in China

The Nimodipine Caveat

An important consideration: nimodipine has Class I evidence for SAH but causes BP lowering effects. Significantly lowering diastolic BP (>20% from baseline) alone is associated with unfavorable outcome in acute ischemic stroke 1. Some experts favor combining nimodipine with vasopressors after aneurysm occlusion.

Common Pitfalls to Avoid

1. Focusing only on mean BP targets while ignoring variability: A patient may have acceptable mean BP but dangerous fluctuations
2. Aggressive BP lowering without smooth titration: Rapid drops followed by rebound increases create harmful variability
3. Intermittent monitoring in high-risk patients: BPV assessment requires frequent measurements—the INTERACT2 protocol used 5 measurements in first 24h and 12 over days 2-7 2
4. Ignoring the timing: BPV peaks in the first 24 hours and has maximal prognostic impact in the hyperacute phase 2

Measurement Considerations

Standard BPV metrics include:

• Standard deviation (SD) of systolic BP—most consistently predictive
• Coefficient of variation (CV)—normalizes for mean BP
• Maximum-minimum difference—captures extreme swings

The 2024 INTERSTROKE analysis of 13,206 patients found that when measured by SD, both systolic BPV (OR 1.13 for SD ≥20 mmHg) and diastolic BPV (OR 1.15 for SD ≥10 mmHg) were associated with poor functional outcomes 7.

The evidence demonstrates that BPV is not merely a marker of disease severity but represents a modifiable aspect of hemodynamic management that directly impacts outcomes through compromised cerebral perfusion in the setting of impaired autoregulation.